GLP-1 agonists can help treat different components of polyendocrine metabolic ovarian syndrome (PMOS), as well as related ...

A new review argues that the mitochondrial peptide MOTS-c acts as a context-dependent stress signal with protective roles in ...

Whatsapp Practical adjustments to food composition, meal sequence, and post-meal movement can significantly improve daily ...

The dialogue on health optimization, rapid physical recovery and longevity has been transformed across social media.

Researchers have engineered salamander-inspired gold-silver nanocages that cascade-target injured kidney cells and their ...

Older adults with metabolic fatty liver disease who started a class of diabetes and weight-loss medicines had fewer liver ...

Older adults with inflammatory arthritis often face delayed diagnosis, but primary care providers can be the first step to ...

What Research Shows About Cancer Risk and Prevention / Breast Cancer, cancer, Cancer Prevention, Cancer research, cancer risk ...

GLP-1 RAs outperformed mineralocorticoid receptor antagonists (MRAs) in cardiovascular protection in resistant hypertension and obesity.

Type 1 diabetes requires lifelong insulin therapy, while some people with Type 2 diabetes can achieve drug-free remission ...

The Medical Possibilities Opened by Two PeptidesIn 2026, research into GLP-1 and orexin is attracting attention as a result ...

Valeriia Simanovskaia, founder and CEO of Biobrokers, argues the next competitive frontier in the GLP-1 market is not another obesity drug but ...